Liquid Biopsies: Emerging non-invasive methods for early detection and monitoring.

Liquid biopsies represent a revolutionary approach to cancer diagnostics, offering a non-invasive alternative to tissue biopsies. By analyzing circulating tumor DNA (ctDNA), exosomes, and other biomarkers in blood, liquid biopsies enable early detection, real-time monitoring, and treatment adjustments. They are particularly valuable for cancers with challenging biopsy procedures, such as pancreatic and lung cancers. Research focuses on enhancing sensitivity and specificity, developing multi-cancer detection platforms, and integrating liquid biopsies into routine care. These advancements hold immense potential to transform cancer management, offering hope for improved outcomes.